Viking Therapeutics share price today

(VKTX)

Viking Therapeutics share price is $42.25 & ₹3,590.24 as on 21 Dec 2024, 2.30 'hrs' IST

$42.25

▲

0.76

(1.83%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Viking Therapeutics share price in Dollar and Rupees. Guide to invest in Viking Therapeutics from India. Also see the sentimental analysis on Indian investors investing in Viking Therapeutics. Get details on the Indian mutual funds that are investing in Viking Therapeutics. Get Analyst recommendations and forecasts along with all the Viking Therapeutics's financials.

Viking Therapeutics share price movements

Today's Low: $42.25
Today's High: $44.96
$42.25
0.0%
Downside
Day's Volatility :6.03%
Upside
6.03%
52 Weeks Low: $17.23
52 Weeks High: $99.41
$42.25
59.22%
Downside
52 Weeks Volatility :82.67%
Upside
57.5%

Viking Therapeutics Returns

Period	Viking Therapeutics, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	-35.01%	-11.1%	0.0%
6 Months	-18.94%	-6.0%	0.0%
1 Year	120.74%	2.7%	0.0%
3 Years	715.64%	0.6%	-19.7%

Viking Therapeutics Key Statistics

in dollars & INR

Previous Close	$41.49
Open	$44.18
Today's High	$44.9623
Today's Low	$42.25
Market Capitalization	$4.6B
Today's Volume	$8.6M
52 Week High	$99.41
52 Week Low	$17.23
Revenue TTM	$0.0
Earnings Per Share (EPS)	$-0.94
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-15.5%

How to invest in Viking Therapeutics from India?

It is very easy for Indian residents to invest directly in Viking Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Viking Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Viking Therapeutics or VKTX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Viking Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Viking Therapeutics shares which would translate to 0.020 fractional shares of Viking Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Viking Therapeutics, in just a few clicks!

Returns in Viking Therapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

Viking Therapeutics investment value today

Current value as on today

₹2,22,938

Returns

₹1,22,938

(+122.94%)

Returns from Viking Therapeutics Stock

₹1,20,742 (+120.74%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Viking Therapeutics

-37.56%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Investment in Viking Therapeutics from India has reduced in the last 30 days as on Dec 22, 2024. -37.56% less purchase transactions for Viking Therapeutics in the last 30 days versus the previous period.

-52%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Viking Therapeutics on INDmoney from India has reduced in the last 30 days as on Dec 22, 2024. -52% less investors are searching Viking Therapeutics in the last 30 days versus the previous period.

Global Institutional Holdings in Viking Therapeutics

FMR Inc
14.91%
Vanguard Group Inc
9.12%
BlackRock Inc
5.41%
State Street Corp
4.19%
JPMorgan Chase & Co
1.90%
Morgan Stanley - Brokerage Accounts
1.68%

Analyst Recommendation on Viking Therapeutics

Buy

94%Buy

5%Hold

0%Sell

Based on 17 Wall street analysts offering stock ratings for Viking Therapeutics(by analysts ranked 0 to 5 stars)

Based on 17 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Viking Therapeutics

What analysts predicted

Upside of 160.36%

Current:

$42.25

Target:

$110.00

Insights on Viking Therapeutics

Price Movement
In the last 3 years, VKTX stock has moved up by 765.8%

Viking Therapeutics Technicals Summary

Sell

Neutral

Buy

Viking Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Viking Therapeutics Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Viking Therapeutics, Inc.	-18.17%	-18.94%	120.74%	715.64%	383.96%
Regeneron Pharmaceuticals, Inc.	-5.73%	-34.03%	-17.38%	12.23%	86.41%
Biontech Se	4.48%	30.56%	7.97%	-55.71%	237.85%
Alnylam Pharmaceuticals, Inc.	-0.55%	10.11%	28.37%	26.29%	108.55%
Vertex Pharmaceuticals Incorporated	-11.79%	-16.36%	-2.55%	77.79%	80.12%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Viking Therapeutics, Inc.	NA	NA	-0.03	-0.95	-0.15	-0.13	NA	8.18
Regeneron Pharmaceuticals, Inc.	17.51	17.51	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.17	0.55	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Viking Therapeutics, Inc.	Buy	$4.6B	383.96%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$77.8B	86.41%	17.51	33.61%
Biontech Se	Buy	$26.7B	237.85%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$30.8B	108.55%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$102.1B	80.12%	32.84	-4.51%

Viking Therapeutics Dividend announcements

Viking Therapeutics Earnings
Viking Therapeutics’s price-to-earnings ratio stands at None
Read More

About Viking Therapeutics

novel therapeutics for metabolic and endocrine disorders.

Organization	Viking Therapeutics
Employees	30
CEO	Dr. Brian Lian Ph.D.
Industry	Health Technology

Management People of Viking Therapeutics

Name	Title
Dr. Brian Lian Ph.D.	President, CEO & Director
Mr. Gregory S. Zante CPA, CPA	Chief Financial Officer
Ms. Marianne Mancini	Chief Operating Officer
Mr. Michael Morneau	Vice President of Finance & Administration
Dr. Geoffrey E. Barker Ph.D.	Senior Vice President of Pharmaceutical Development

Important FAQs about investing in Viking Therapeutics from India :

What is Viking Therapeutics share price today?

Viking Therapeutics share price today stands at $42.25, Open: $44.18 ; Previous Close: $41.49 ; High: $44.96 ; Low: $42.25 ; 52 Week High: $99.41 ; 52 Week Low: $17.23. The stock opens at $44.18, after a previous close of $41.49. The stock reached a daily high of $44.96 and a low of $42.25, with a 52-week high of $99.41 and a 52-week low of $17.23.

Can Indians buy Viking Therapeutics shares?

Yes, Indians can invest in the Viking Therapeutics (VKTX) from India.

With INDmoney, you can buy Viking Therapeutics at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Viking Therapeutics at zero transaction cost.

How can I buy Viking Therapeutics shares from India?

It is very easy to buy Viking Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Viking Therapeutics be purchased?

Yes, you can buy fractional shares of Viking Therapeutics with INDmoney app.

What are the documents required to start investing in Viking Therapeutics stocks?

To start investing in Viking Therapeutics, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.